Moderate

Routine antenatal anti-D prophylaxis (RhD-negative)

RAADP · Obstetric
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Routine antenatal anti-D immunoglobulin prevents RhD alloimmunisation in non-sensitised RhD-negative women by neutralising fetal RhD-positive cells that cross the placenta, reducing haemolytic disease in current and future pregnancies.

Red flags

  • Antibody screen showing existing anti-D (sensitisation already occurred)
  • Large feto-maternal haemorrhage on Kleihauer needing extra dosing
  • Missed or delayed dosing after a sensitising event
  • Abdominal trauma or antepartum haemorrhage in an RhD-negative woman

Assessment

Differential diagnosis

  • Already sensitised (anti-D antibodies present)
  • RhD-positive mother (prophylaxis not needed)
  • Fetal RhD-negative on cffDNA (prophylaxis may be avoided)
  • Other red-cell antibody alloimmunisation
  • Weak/partial D phenotype requiring specialist typing

Investigations

  • Blood group and antibody screen at booking and 28 weeks
  • Antibody screen to confirm non-sensitised status before giving prophylaxis
  • Cell-free fetal DNA RhD genotyping where available to target prophylaxis
  • Kleihauer or flow cytometry after a potentially sensitising event to quantify feto-maternal haemorrhage
  • Cord blood group and direct antiglobulin test at delivery

Management

  • Confirm the woman is RhD negative and non-sensitised at booking
  • Offer cffDNA fetal RhD typing where available and avoid prophylaxis if fetus is RhD negative
  • Give routine antenatal anti-D at 28 weeks (single-dose regimen) or at 28 and 34 weeks (two-dose regimen)
  • Take the 28-week antibody screen before administering anti-D
  • Give additional anti-D promptly (within 72 hours) after any potentially sensitising event
  • Perform Kleihauer after sensitising events beyond 20 weeks and give extra anti-D for large bleeds
  • Check cord blood at delivery and give postnatal anti-D within 72 hours if baby is RhD positive
  • Document all doses and the reason for any omission

Drugs & doses

Anti-D immunoglobulin 1500 units IM at 28 weeks (single-dose RAADP)
Anti-D immunoglobulin 500 units IM at 28 and 34 weeks (two-dose regimen)
Anti-D immunoglobulin 250 units IM for sensitising events before 20 weeks; 500 units plus Kleihauer-guided top-up after 20 weeks
Postnatal anti-D immunoglobulin 500 units IM within 72 hours if neonate RhD positive

Disposition

Community administration of routine doses; refer sensitised women or those with significant feto-maternal haemorrhage to fetal medicine for surveillance.

Complications & pitfalls

  • Alloimmunisation if prophylaxis omitted or delayed
  • Haemolytic disease of the fetus and newborn in future pregnancies
  • Inadequate dosing after large feto-maternal haemorrhage
  • Rare anaphylaxis to immunoglobulin

Exam pearls

  • Routine antenatal prophylaxis does not replace event-driven anti-D
  • Give anti-D within 72 hours but it retains some benefit up to 10 days
  • cffDNA typing can spare around 40% of RhD-negative women unnecessary prophylaxis
  • A positive antibody screen for anti-D means she is already sensitised and prophylaxis is futile

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.